Omeros (OMER) Capital Expenditures (2010 - 2025)
Omeros' (OMER) quarterly Capital Expenditures came in at $11000.0 in Q3 2025, up 1000.0% year-on-year from $1000.0 in Q3 2024, and down 15.38% quarter-over-quarter from $13000.0 in Q2 2025.
Omeros (OMER) Capital Expenditures (2010 - 2025) Analysis & Trends
Omeros has disclosed Capital Expenditures across 16 years of filings, most recently posting $11000.0 for Q3 2025.
- Capital Expenditures for Q3 2025 came in at $11000.0, up 1000.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $24000.0 (down 83.78% YoY), and the FY2025 annual result was $65000.0, down 60.61% from the prior year.
- Capital Expenditures came in at $11000.0 for Q3 2025 at Omeros, down from $13000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $275000.0 in Q2 2023 to a low of -$3000.0 in Q3 2022.
- The 5-year median for Capital Expenditures is $37000.0 (2023), against an average of $58937.5.
- Across the five-year window, Capital Expenditures plunged 102.91% in 2022 and soared 1200.0% in 2023, its largest moves.
- Omeros' Capital Expenditures stood at $74000.0 in 2021, then plunged by 82.43% to $13000.0 in 2022, then jumped by 807.69% to $118000.0 in 2023, then plunged by 77.97% to $26000.0 in 2024, then tumbled by 57.69% to $11000.0 in 2025.
- The last three Capital Expenditures figures came in at $11000.0 (Q3 2025), $13000.0 (Q2 2025), and $41000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Omeros | 737.87 Mn | 602.55 Mn | 9.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 11,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Mar 31, 2025 | 41,000.00 |
| Mar 31, 2025 | 41,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 80,000.00 |
| Jun 30, 2024 | 80,000.00 |
| Mar 31, 2024 | 58,000.00 |
| Mar 31, 2024 | 58,000.00 |
| Dec 31, 2023 | 118,000.00 |
| Dec 31, 2023 | 118,000.00 |
| Sep 30, 2023 | 33,000.00 |
| Sep 30, 2023 | 33,000.00 |
| Jun 30, 2023 | 275,000.00 |
| Jun 30, 2023 | 275,000.00 |